The photobiostimulation devices market is witnessing strong growth, driven by advancements in non-invasive therapies and rising awareness of phototherapy's clinical benefits. According to a recent analysis by Expert Market Research, the global photobiostimulation devices market was valued at USD 10.50 billion in 2024. The market is expected to grow at a CAGR of 9.10% between 2025 and 2034, reaching approximately USD 25.09 billion by 2034. This growth trajectory highlights the increasing...

The North America Fluoroscopy Market has shown steady growth, driven by ongoing technological advancements and expanding clinical applications. Valued at USD 2.20 billion in 2024, the market is anticipated to grow at a compound annual growth rate (CAGR) of 4.70% between 2025 and 2034, potentially reaching USD 3.48 billion by 2034. This growth reflects increasing demand in healthcare and pharmaceuticals for advanced imaging technologies that aid in real-time diagnostics and minimally invasive...

Transitional cell carcinoma (TCC), also known as urothelial carcinoma, is a malignancy originating in the urothelial cells lining the urinary tract, including the bladder, ureters, and renal pelvis. Although upper urinary tract transitional cell carcinoma (UTTCC) accounts for only about 5% of all urothelial cancers and less than 10% of kidney tumors, its rising incidence is prompting growing clinical and research attention. As outlined in the Expert Market Research Transitional Cell Carcinoma...

Expert Market Research reports a significant shift in the therapeutic landscape of substance use disorders (SUDs), driven by rising prevalence and scientific advances. According to the 2023 National Survey on Drug Use and Health (NSDUH), approximately 48.5 million Americans aged 12 and older were affected by substance use disorder (SUD) in the past year, representing 16.7% of the U.S. population. This data highlights the urgent need for effective and scalable interventions. The Substance...